Impact of self-reported fasting duration on lipid profile variability, cardiovascular risk stratification and metabolic syndrome diagnosis

Página do item simplificado
dc.citation.issue2
dc.citation.volumev. 62
dc.contributor.authorJanovsky, Carolina Castro Porto Silva [UNIFESP]
dc.contributor.authorLaurinavicius, Antonio
dc.contributor.authorCesena, Fernando
dc.contributor.authorValente, Viviane
dc.contributor.authorFerreira, Carlos Eduardo
dc.contributor.authorMangueira, Cristovao
dc.contributor.authorConceicao, Raquel
dc.contributor.authorSantos, Raul D.
dc.contributor.authorBittencourt, Marcio Sommer
dc.coverageRio De Janeiro, Rj
dc.date.accessioned2020-07-20T16:31:17Z
dc.date.available2020-07-20T16:31:17Z
dc.date.issued2018
dc.description.abstractObjective: We sought to investigate the impact of self-reported fasting duration times on the lipid profile results and its impact on the cardiovascular risk stratification and metabolic syndrome diagnosis. Subjects and methods: We analyzed data from all consecutive individuals evaluated in a comprehensive health examination at the Hospital Israelite Albert Einstein from January to December 2015. We divided these patients in three groups, according to the fasting duration recalled (< 8h, 8-12h and > 12h). We calculated the global cardiovascular risk and diagnosed metabolic syndrome according to the current criteria and estimated their change according to fasting duration. Results: A total of 12,196 (42.3 +/- 9.2 years-old, 30.2% females) patients were evaluated. The distribution of cardiovascular risk was not different among groups defined by fasting duration in both men and women (p = 0.547 for women and p = 0.329 for men). Similarly, the prevalence of metabolic syndrome was not influenced by the fasting duration (p = 0.431 for women and p = 0.166 for men). Conclusion: Self-reported fasting duration had no significant impact on the lipid profile results, including triglyceride levels. Consequently, no changes on the cardiovascular risk stratification using the Framingham risk score nor changes on the prevalence of metabolic syndrome were noted.en
dc.description.affiliationUniv Fed Sao Paulo Unifesp, Endocrinol & Metab, Sao Paulo, SP, Brazil
dc.description.affiliationHIAE, Med Prevent, Sao Paulo, SP, Brazil
dc.description.affiliationHIAE, Lab Clin, Sao Paulo, SP, Brazil
dc.description.affiliationUniv Sao Paulo InCoP HCFMUSP, Fac Med, Hosp Clin, Inst Coracao, Sao Paulo, SP, Brazil
dc.description.affiliationHIAE, Med Prevent, Fac Med, Sao Paulo, SP, Brazil
dc.description.affiliationUnifespUniv Fed Sao Paulo Unifesp, Endocrinol & Metab, Sao Paulo, SP, Brazil
dc.description.sourceWeb of Science
dc.format.extent187-192
dc.identifierhttp://dx.doi.org/10.20945/2359-3997000000023
dc.identifier.citationArchives Of Endocrinology Metabolism. Rio De Janeiro, Rj, v. 62, n. 2, p. 187-192, 2018.
dc.identifier.doi10.20945/2359-3997000000023
dc.identifier.fileS2359-39972018000200187.pdf
dc.identifier.issn2359-3997
dc.identifier.scieloS2359-39972018000200187
dc.identifier.urihttps://repositorio.unifesp.br/handle/11600/55851
dc.identifier.wosWOS:000432093700009
dc.language.isoeng
dc.publisherSbem-Soc Brasil Endocrinologia & Metabologia
dc.relation.ispartofArchives Of Endocrinology Metabolism
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectTriglyceridesen
dc.subjectcardiovascular risken
dc.subjectfastingen
dc.subjectmetabolic syndromeen
dc.titleImpact of self-reported fasting duration on lipid profile variability, cardiovascular risk stratification and metabolic syndrome diagnosisen
dc.typeinfo:eu-repo/semantics/article
Arquivos
Pacote Original
Agora exibindo 1 - 1 de 1
Imagem de Miniatura
Nome:
S2359-39972018000200187.pdf
Tamanho:
174.99 KB
Formato:
Adobe Portable Document Format
Descrição:
Baixar
Coleções
EPM - Artigos